limited to

200

Attendees

limited to

150

Companies

50

Speakers

Testimonials

"I was enjoying the conference a lot. This one was one of the most professional conferences I have attended so far because it gathers the best international specialists in this field."

Hanna Hlushchenko, Business Development Director, Cannexpor Pharma Europe

"Our VP Business Development was very impressed with the networking opportunities at the conference."

Debra Senger, Founder and CEO, PhyeinMed

"The conference was fantastic! There were lots of B2B relationships and I encourage anyone to attend."

Mark Lewis, President, Napro Research

How It Works

Through a mix of case-study presentations, interactive roundtable discussions, Q&A sessions and hands-on workshops, you will gain inspiring perspectives. The multi-stream format allows you to move freely between the sessions. Create your own personal agenda from the case studies and interactive round tables. If you can't participate in the conference onsite, you have the possibility to get the insights of the decision-makers via live streaming.

Move freely between the streams
Customize your program
Attend the sessions of most interest

Get Inspired by the Sessions You Choose from All Streams

Europe 1 (Germany and the wider EU market)
Target Group

Leaders along the hemp and cannabis value chain looking to enter the German and wider EU cannabis industry, or intend to expand their footprint in these markets

Key Topics
  • Legalization in Europe and particularly Germany
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments
Europe 2 (France and the Mediterranean)
Target Group

Leaders along the hemp and cannabis value chain looking to enter the French & Mediterranean hemp and cannabis industry, or intend to expand their footprint in these markets

Key Topics
  • Legalization in France and the Mediterranean
  • Business development
  • Market development
  • Marketing strategies
  • Manufacturing best practices
  • Cultivation best practices
  • Best practice production processes
  • New industry developments

Agenda

Filter by Track:

TUESDAY, JUNE 22ND

9:00

Introduction of the Chairman by World Class Business Leaders

Marcello Bergamini

General Manager
Crystal Hemp
Switzerland

This session is in English

Introduction of the Chairman by World Class Business Leaders

Marcello Bergamini

General Manager
Crystal Hemp
Switzerland

This session is in English

Introduction of the Chairman by World Class Business Leaders

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

Introduction of the Chairman by World Class Business Leaders

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

9:15

Regulations and Harmonizations for the EU Market

  • Latest developments in Europe from Bedrocan’s point of view
  • Current regulatory situation
  • Importance of harmonization

Tjalling Erkelens

Founder & CEO
Bedrocan International
The Netherlands

This session is in English

9:45

Global Challenges for Access to Medical Cannabis: A Regulatory and Safety Perspective

  • Current requirements for cannabis-derived medicinal products
  • Best ways to comply with regulations for products aimed for the EU & Non-EU markets
  • Vigilance of medical cannabis products
  • Pricing and reimbursement for medical cannabis in various markets

Parminder Kaur

CEO
RegPak BioPharma
The Netherlands / Romania

This session is in English

10:00

Poland as a Gateway to the European Medical Cannabis Market

  • Canadian market size, German working culture and Italian fantasy
  • Manual vs automatized - outsourcing in manufacturing of cannabis
  • Education, distribution and reliable partners - key success factors

Zbigniew Pisarski

Founder & Chairman of the Supervisory Board
CanPoland
Poland

This session is in English

10:15

Coffee Break with Networking

10:45

Portugal: Europe's Newest Active Medical Market

  • The regulatory landscape
  • The current situation
  • The future potential

Steven George

Business Development Manager
Tilray
Portugal / Spain

This session is in English

11:15

The Global Cannabis Industry: Regional Import & Export Dynamics

  • Current state & figures of the global cannabis sector
  • Emerging import & export dynamics
  • Opportunities, challenges & insights

Giadha A. DeCarcer

Founder and Executive Chair
New Frontier Data
USA

This session is in English

11:30

Understanding the Correlation between Cannabis Brand Protection and Business Growth

  • 4 processes: Authenticate, Track & Trace, Customer Engagement, Online Brand Monitoring
  • 360° approach to brand protection for the cannabis industry
  • Reducing counterfeit & diversion for immediate ROI
  • How to engage your customer to increase sales

Paul Vitali

VP Business Development EMEA
VerifyMe
USA / Switzerland

This session is in English

11:55

Extraction and Purification of Cannabinoids Using the Most Sustainable Solvent: CO₂

  • Extraction Cost: Why Supercritical CO₂ Extraction (SFE) is the Lowest Cost Method
  • Purification: Why SFC/CO₂ chromatography is the lowest cost for precision ingredients
  • Future: Scaling up processes such as Minor Cannabinoid Isolation and removing impurities/pesticides

Todd Palcic

President
Thar Process
USA

This session is in English

Extraction and Purification of Cannabinoids Using the Most Sustainable Solvent: CO₂

  • Extraction Cost: Why Supercritical CO₂ Extraction (SFE) is the Lowest Cost Method
  • Purification: Why SFC/CO₂ chromatography is the lowest cost for precision ingredients
  • Future: Scaling up processes such as Minor Cannabinoid Isolation and removing impurities/pesticides

Todd Palcic

President
Thar Process
USA

This session is in English

12:10

Lobbying for Medicinal Cannabis in Germany

  • Introduction to the Federal Association of Pharmaceutical Cannabinoid Companies (BPC)
  • Goals & objectives of the BPC
  • Current initiatives of the BPC

Linus Maximilian Weber

Head of Recruitment
Federal Association of Pharmaceutical Cannabinoid Companies (BPC)
Germany

This session is in English

Lobbying for Medicinal Cannabis in Germany

  • Introduction to the Federal Association of Pharmaceutical Cannabinoid Companies (BPC)
  • Goals & objectives of the BPC
  • Current initiatives of the BPC

Linus Maximilian Weber

Head of Recruitment
Federal Association of Pharmaceutical Cannabinoid Companies (BPC)
Germany

This session is in English

Cannabidiol in Clinical Cosmetic Application

  • Cannabidiol in cosmetic preparations and evaluation of effectiveness with respect to the concentration used
  • Clinical tests for the validation of cosmetic efficacy and safety
  • Application of cannabidiol in medical devices

Antonio Mazzucco

Qualified Person
Crystal Hemp
Switzerland

This session is in English

Cannabidiol in Clinical Cosmetic Application

  • Cannabidiol in cosmetic preparations and evaluation of effectiveness with respect to the concentration used
  • Clinical tests for the validation of cosmetic efficacy and safety
  • Application of cannabidiol in medical devices

Antonio Mazzucco

Qualified Person
Crystal Hemp
Switzerland

This session is in English

12:25

Malta: An Ideal Jurisdiction for Medical Cannabis

  • Why Malta: Legal and regulatory framework of medical cannabis industry
  • Process
  • Current scenario

Marion Zammit

Head Medical Cannabis Cluster
Malta Enterprise
Malta

This session is in English

Malta: An Ideal Jurisdiction for Medical Cannabis

  • Why Malta: Legal and regulatory framework of medical cannabis industry
  • Process
  • Current scenario

Marion Zammit

Head Medical Cannabis Cluster
Malta Enterprise
Malta

This session is in English

Unlocking the French Medical Cannabis Market: A Concerted Effort

  • The French cannabis market: Where are we now?
  • Opportunities and challenges faced by the cannabis industry players in France
  • Medical cannabis education: How France is creating a blueprint for Europe

Christopher Kainz

Managing Director
Aurora France
France / Germany

This session is in English

Unlocking the French Medical Cannabis Market: A Concerted Effort

  • The French cannabis market: Where are we now?
  • Opportunities and challenges faced by the cannabis industry players in France
  • Medical cannabis education: How France is creating a blueprint for Europe

Christopher Kainz

Managing Director
Aurora France
France / Germany

This session is in English

12:55

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is the current regulatory situation in the EU market? - Tjalling Erkelens, Founder & CEO, Bedrocan International


How is Poland a gateway to the European medical cannabis market? - Zbigniew Pisarski, Founder & Chairman of the Supervisory Board, CanPoland


How can cannabinoids be extracted and purified using CO₂? - Todd Palcic, President, Thar Process


How can I join the BPC, put medicinal cannabis on the political agenda and further educate key stakeholders to expand the medicinal cannabis market? - Linus Maximilian Weber, Head of Recruitment, Federal Association of Pharmaceutical Cannabinoid Companies (BPC)


How is Malta primed as the future manufacturing hub for medical cannabis exports into the European market? - Marion Zammit, Head Medical Cannabis Cluster, Malta Enterprise

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What is the current regulatory situation in the EU market? - Tjalling Erkelens, Founder & CEO, Bedrocan International


How is Poland a gateway to the European medical cannabis market? - Zbigniew Pisarski, Founder & Chairman of the Supervisory Board, CanPoland


How can cannabinoids be extracted and purified using CO₂? - Todd Palcic, President, Thar Process


How can I join the BPC, put medicinal cannabis on the political agenda and further educate key stakeholders to expand the medicinal cannabis market? - Linus Maximilian Weber, Head of Recruitment, Federal Association of Pharmaceutical Cannabinoid Companies (BPC)


How is Malta primed as the future manufacturing hub for medical cannabis exports into the European market? - Marion Zammit, Head Medical Cannabis Cluster, Malta Enterprise

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the global challenges for access to medical cannabis? - Parminder Kaur, CEO, RegPak BioPharma


How will the global cannabis industry look like in the future? - Giadha A. DeCarcer, Founder and Executive Chair, New Frontier Data


How can companies protect their brands and how does it help their businesses grow? - Paul Vitali, VP Business Development EMEA, VerifyMe


How can cannibidiol be used in cosmetic preparations? - Antonio Mazzucco, Qualified Person, Crystal Hemp


Where does the potential for the French medical cannabis market lie? - Christopher Kainz, Managing Director, Aurora France

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the global challenges for access to medical cannabis? - Parminder Kaur, CEO, RegPak BioPharma


How will the global cannabis industry look like in the future? - Giadha A. DeCarcer, Founder and Executive Chair, New Frontier Data


How can companies protect their brands and how does it help their businesses grow? - Paul Vitali, VP Business Development EMEA, VerifyMe


How can cannibidiol be used in cosmetic preparations? - Antonio Mazzucco, Qualified Person, Crystal Hemp


Where does the potential for the French medical cannabis market lie? - Christopher Kainz, Managing Director, Aurora France

13:40

Lunch with Networking

15:10

The Future of IP in the Cannabis Sector

  • Potentially relevant patent law precedents
  • The current landscape in cannabis IP
  • What does the future hold for cannabis IP?

David Traylor

Senior Managing Director
Golden Eagle Partners
USA

This session is in English

The Future of IP in the Cannabis Sector

  • Potentially relevant patent law precedents
  • The current landscape in cannabis IP
  • What does the future hold for cannabis IP?

David Traylor

Senior Managing Director
Golden Eagle Partners
USA

This session is in English

CBD Regulation in France: What is About to Change?

  • The content of the new regulation
  • Pending issues
  • What it means for economic actors
  • France: the future European leader?

Ludovic Rachou

President
Union des industriels pour la valorisation des extraits de chanvre (UIVEC)
France

This session is in English

CBD Regulation in France: What is About to Change?

  • The content of the new regulation
  • Pending issues
  • What it means for economic actors
  • France: the future European leader?

Ludovic Rachou

President
Union des industriels pour la valorisation des extraits de chanvre (UIVEC)
France

This session is in English

15:40

Developments in the Regulatory Environment in Germany and wider Europe

  • Current regulatory market in Germany and the EU market
  • Challenges and opportunities
  • Future outlook on EU regulations in cannabis and CBD

Peter Homberg

Partner
Dentons Europe
Germany

This session is in English

Developments in the Regulatory Environment in Germany and wider Europe

  • Current regulatory market in Germany and the EU market
  • Challenges and opportunities
  • Future outlook on EU regulations in cannabis and CBD

Peter Homberg

Partner
Dentons Europe
Germany

This session is in English

Critical Issues of Medical Cannabis in the Italian Market

  • Supply and distribution in pharmacies
  • Critical points and improvements
  • New ideas and latest updates

Marco Ternelli

CEO
Farmagalenica
Italy

This session is in English

Critical Issues of Medical Cannabis in the Italian Market

  • Supply and distribution in pharmacies
  • Critical points and improvements
  • New ideas and latest updates

Marco Ternelli

CEO
Farmagalenica
Italy

This session is in English

16:10

Regulatory Requirements for Cannabis Production in Germany

  • Interaction with the Cannabis Agency
  • Security measures
  • Distribution to pharmacies
  • Production in Germany versus imports

Dr. Constantin von der Groeben

Co‑Founder & Managing Director
Demecan
Germany

This session is in English

Regulatory Requirements for Cannabis Production in Germany

  • Interaction with the Cannabis Agency
  • Security measures
  • Distribution to pharmacies
  • Production in Germany versus imports

Dr. Constantin von der Groeben

Co‑Founder & Managing Director
Demecan
Germany

This session is in English

Cross-Comparison between the French and Italian CBD markets

  • Background of the survey
  • Preferences and use profiles of medical and non-medical consumers
  • Patterns of consumption during COVID times

Davide Fortin

Senior Associate
MPG Consulting (ex Marijuana Policy Group)
France

This session is in English

Cross-Comparison between the French and Italian CBD markets

  • Background of the survey
  • Preferences and use profiles of medical and non-medical consumers
  • Patterns of consumption during COVID times

Davide Fortin

Senior Associate
MPG Consulting (ex Marijuana Policy Group)
France

This session is in English

16:40

Coffee Break with Networking

17:10

Opportunities for Entering or Investing in the Polish Medical Cannabis Market

  • History of Poland's medical cannabis industry
  • Entering the Polish market
  • What do investors look out for when it comes to Polish medical cannabis companies?

Arek Kuich

Partner
Cannabis Partners
Poland

This session is in English

Opportunities for Entering or Investing in the Polish Medical Cannabis Market

  • History of Poland's medical cannabis industry
  • Entering the Polish market
  • What do investors look out for when it comes to Polish medical cannabis companies?

Arek Kuich

Partner
Cannabis Partners
Poland

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sánchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sánchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

17:40

Attracting Investments for Medical Cannabis Startups: A Case Study of Sanity Group's Success Story

  • How were 20 million euros raised? The success story of Sanity Group
  • The outlook of the German market: Changes in the investing environment and best strategies to use
  • Future trends and outlook in the world of medical cannabis startups

Finn Hänsel

Founder & Managing Director
Sanity Group
Germany

This session is in English

Attracting Investments for Medical Cannabis Startups: A Case Study of Sanity Group's Success Story

  • How were 20 million euros raised? The success story of Sanity Group
  • The outlook of the German market: Changes in the investing environment and best strategies to use
  • Future trends and outlook in the world of medical cannabis startups

Finn Hänsel

Founder & Managing Director
Sanity Group
Germany

This session is in English

Regulation and Quality Control in the CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: How can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

Regulation and Quality Control in the CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: How can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

18:10

Prospects of Medical Cannabis Products in the German Market

  • Production of medical cannabis extracts in Australia
  • Collaboration with Little Green Pharma: Bringing EU-GMP Australian products into Germany
  • Future prospects of Australian medical cannabis products in the German market

Dr. Stefan Feuerstein

Managing Director
AMP German Cannabis Group
Germany

This session is in English

Prospects of Medical Cannabis Products in the German Market

  • Production of medical cannabis extracts in Australia
  • Collaboration with Little Green Pharma: Bringing EU-GMP Australian products into Germany
  • Future prospects of Australian medical cannabis products in the German market

Dr. Stefan Feuerstein

Managing Director
AMP German Cannabis Group
Germany

This session is in English

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

CEO & Founder
DelleD
France

This session is in English

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

CEO & Founder
DelleD
France

This session is in English

18:40

Outlook for CBD Products in EU's Food & Beverage Industry

  • Novel Foods regulation and how it affects the CBD industry
  • Use of CBD products in Europe's F&B industry
  • Outlook ahead

Sebastian Kamphorst

CEO
Becanex
Germany

This session is in English

Outlook for CBD Products in EU's Food & Beverage Industry

  • Novel Foods regulation and how it affects the CBD industry
  • Use of CBD products in Europe's F&B industry
  • Outlook ahead

Sebastian Kamphorst

CEO
Becanex
Germany

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

19:10

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How has the regulatory environment in Germany and wider Europe developed? - Peter Homberg, Partner, Dentons Europe


What are the regulatory requirements for cannabis production in Germany? - Dr. Constantin von der Groeben, Co‑Founder & Managing Director, Demecan


How can medical cannabis startups attract investments successfully? - Finn Hänsel, Founder & Managing Director, Sanity Group


What are the prospects of medical cannabis products in Germany? - Dr. Stefan Feuerstein, Managing Director, AMP German Cannabis Group


What are the prospects of CBD products in Europe's food & beverage industry? - Sebastian Kamphorst, CEO, Becanex

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How has the regulatory environment in Germany and wider Europe developed? - Peter Homberg, Partner, Dentons Europe


What are the regulatory requirements for cannabis production in Germany? - Dr. Constantin von der Groeben, Co‑Founder & Managing Director, Demecan


How can medical cannabis startups attract investments successfully? - Finn Hänsel, Founder & Managing Director, Sanity Group


What are the prospects of medical cannabis products in Germany? - Dr. Stefan Feuerstein, Managing Director, AMP German Cannabis Group


What are the prospects of CBD products in Europe's food & beverage industry? - Sebastian Kamphorst, CEO, Becanex

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the new CBD regulations in France? - Ludovic Rachou, President, Union des industriels pour la valorisation des extraits de chanvre (UIVEC)


What are the critical issues in the Italian medical cannabis market? - Marco Ternelli, CEO, Farmagalenica


What are the consumption habits of French and Italian CBD users? - Davide Fortin, Senior Associate, MPG Consulting (ex Marijuana Policy Group)


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sánchez, Founder and Lawyer, NOOA Avocats


Regulation and Quality Control in the CBD Industry - Sébastien Béguerie, CEO & Founder, Alpha‑CAT


Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, CEO & Founder, DelleD


France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the new CBD regulations in France? - Ludovic Rachou, President, Union des industriels pour la valorisation des extraits de chanvre (UIVEC)


What are the critical issues in the Italian medical cannabis market? - Marco Ternelli, CEO, Farmagalenica


What are the consumption habits of French and Italian CBD users? - Davide Fortin, Senior Associate, MPG Consulting (ex Marijuana Policy Group)


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sánchez, Founder and Lawyer, NOOA Avocats


Regulation and Quality Control in the CBD Industry - Sébastien Béguerie, CEO & Founder, Alpha‑CAT


Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, CEO & Founder, DelleD


France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud

19:55

Summary of the First Day of the Conference and Projects Introduction

20:10

Evening Reception Sponsored by Crystal Hemp

Engage in exciting conversations. Strengthen your network after a day full of knowledge sharing, groundbreaking presentations, and interesting conversations. Join delegates and speakers in the relaxed atmosphere of the event venue.

This session is in English

WEDNESDAY, JUNE 23RD

8:00

Introduction of the Chairman by World Class Business Leaders

Robert Noveski

Founder & CEO
Sinceritas
Germany / North Macedonia

This session is in English

Introduction of the Chairman by World Class Business Leaders

Robert Noveski

Founder & CEO
Sinceritas
Germany / North Macedonia

This session is in English

Introduction of the Chairman by World Class Business Leaders

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

Introduction of the Chairman by World Class Business Leaders

Sébastien Béguerie

CEO & Founder
Alpha‑CAT
France

This session is in English

8:15

Distributing German-Cultivated Medical Cannabis Flowers for the German Market on Behalf of the Cannabis Agency

  • Production and cultivation by local cannabis partners
  • Distribution of locally-cultivated cannabis for the German market on behalf of the Cannabis Agency
  • Outlook for supply of medical cannabis flowers in Germany

Johann Benedikt Sons

CEO & Co‑Founder
Cansativa
Germany

This session is in English

8:45

Bernhard Babel

Co‑CEO
Eurox Group
Germany

The European Medicinal Cannabis Market: A Perspective from Seeds to Patients

  • Eurox is a vertical medical cannabis company (from seed to patient) with its headquarters in Europe / Germany
  • Development of the market in Europe has been positive but also slightly disappointing
  • Patient experiences show high benefits of medical cannabis
  • Important to ensure highest quality along the full value chain and backing by local science and research to face and ultimately remove concerns among medical practitioners
This session is in English
David Reckeweg-Lecompte

Co‑CEO
Eurox Group
Germany

9:00

Natural Extracts Quality: A Challenge for the Development of the Medical Cannabis Market

  • Quality of cannabis raw materials
  • GMP certification to enter the pharmaceutical market
  • The pathway to achieving the quality required by the pharmaceutical industry

Nora Rossini

Scientific Affairs Manager
Linnea
Switzerland

This session is in English

9:15

Coffee Break with Networking

9:45

Dosing: Where Does The Responsibility Lie?

  • The problem with measuring a plant
  • Industry challenges from lack of data
  • The cultivator-consumer solution

Bradley Moore

CEO
Global Cannabis Applications Corporation
Canada

This session is in English

10:15

Cannabis: International Industry, Local Markets

  • Fast globalization of the cannabis industry
  • Development of local markets are developing - different stages with different requirements
  • Overall market characterized by things like regulatory complexity, cultural differences, and purchasing and consumption habits
  • Success relies on local partnerships to address markets

Benjamin Vinograd

Head of Europe
Clever Leaves
Portugal

This session is in English

10:40

Cannabis 2.0: Next Steps for Medical Cannabis and Cannabis-Infused Product Innovations

  • Advancements in medical cannabis delivery technologies
  • Expanding beyond smoked pot
  • Innovative consumers

Grzegorz Kiełbowicz

CEO
Healthcann
Poland

This session is in English

Cannabis 2.0: Next Steps for Medical Cannabis and Cannabis-Infused Product Innovations

  • Advancements in medical cannabis delivery technologies
  • Expanding beyond smoked pot
  • Innovative consumers

Grzegorz Kiełbowicz

CEO
Healthcann
Poland

This session is in English

Last Call for Flight #LH686 to TLV - A tour of the Israeli Medical Cannabis Market

  • Opportunities in the Israeli medical cannabis market
  • Challenges in the Israeli medical cannabis market
  • How to prepare for your trip?

Rachel Dangur

Commercial Manager ‑ Israel
Clever Leaves
Israel

This session is in English

Last Call for Flight #LH686 to TLV - A tour of the Israeli Medical Cannabis Market

  • Opportunities in the Israeli medical cannabis market
  • Challenges in the Israeli medical cannabis market
  • How to prepare for your trip?

Rachel Dangur

Commercial Manager ‑ Israel
Clever Leaves
Israel

This session is in English

11:10

Ensuring Quality of Colombia-Grown Cannabis for the European Market: How is it Done?

  • SWOT analysis of the Colombian cannabis cultivation market
  • Supplying the European market with Colombia-grown cannabis
  • Future market trends and opportunities ahead

Oliver Zugel

Founder & CEO
Foliumed
Spain / Colombia

This session is in English

Ensuring Quality of Colombia-Grown Cannabis for the European Market: How is it Done?

  • SWOT analysis of the Colombian cannabis cultivation market
  • Supplying the European market with Colombia-grown cannabis
  • Future market trends and opportunities ahead

Oliver Zugel

Founder & CEO
Foliumed
Spain / Colombia

This session is in English

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

11:40

Poland and North Macedonia as Emerging Markets for Medical Cannabis Business

  • Poland as the second biggest medical cannabis market in Europe: An overview of the current situation, opportunities, and forecast
  • North Macedonia's medical cannabis industry and current status
  • Meeting Europe's pharmaceutical standards
  • Translating North American and European know-how to reach the GMP standards

Zlatko Keskovski

Founder & CEO
Pharmacann International / NYSK Holdings
Poland / North Macedonia

This session is in English

Poland and North Macedonia as Emerging Markets for Medical Cannabis Business

  • Poland as the second biggest medical cannabis market in Europe: An overview of the current situation, opportunities, and forecast
  • North Macedonia's medical cannabis industry and current status
  • Meeting Europe's pharmaceutical standards
  • Translating North American and European know-how to reach the GMP standards

Zlatko Keskovski

Founder & CEO
Pharmacann International / NYSK Holdings
Poland / North Macedonia

This session is in English

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: History and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: History and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

12:10

Expansion Strategies for European Cannabis Companies

  • Advantages of expanding into countries with high barriers of entry
  • Viable long-term business plans and models
  • Avoiding mistakes made in the past in Canada

Robert Noveski

Founder & CEO
Sinceritas
Germany / North Macedonia

This session is in English

Expansion Strategies for European Cannabis Companies

  • Advantages of expanding into countries with high barriers of entry
  • Viable long-term business plans and models
  • Avoiding mistakes made in the past in Canada

Robert Noveski

Founder & CEO
Sinceritas
Germany / North Macedonia

This session is in English

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

CEO & Co‑Founder
Plantik Biosciences
France

This session is in English

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

CEO & Co‑Founder
Plantik Biosciences
France

This session is in English

12:40

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cannabis: International Industry, Local Markets - Benjamin Vinograd, Head of Europe, Clever Leaves


What are the next steps for Polish medical cannabis and cannabis-infused product innovations? - Grzegorz Kiełbowicz, CEO, Healthcann


How are Poland and North Macedonia primed as emerging markets for EU's medical cannabis industry? - Zlatko Keskovski, Founder & CEO, Pharmacann International / NYSK Holdings


How can European cannabis companies expand successfully? - Robert Noveski, Founder & CEO, Sinceritas

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cannabis: International Industry, Local Markets - Benjamin Vinograd, Head of Europe, Clever Leaves


What are the next steps for Polish medical cannabis and cannabis-infused product innovations? - Grzegorz Kiełbowicz, CEO, Healthcann


How are Poland and North Macedonia primed as emerging markets for EU's medical cannabis industry? - Zlatko Keskovski, Founder & CEO, Pharmacann International / NYSK Holdings


How can European cannabis companies expand successfully? - Robert Noveski, Founder & CEO, Sinceritas

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the plans to distribute locally-cultivated medical cannabis flowers for the German market? - Johann Benedikt Sons, CEO & Co‑Founder, Cansativa


From seeds to patients, how does the European medical cannabis market look like? - Bernhard Babel, Co‑CEO, Eurox Group and David Reckeweg-Lecompte, Co‑CEO, Eurox Group


How is the quality of natural extracts a challenge for the medical cannabis industry? - Nora Rossini, Scientific Affairs Manager, Linnea


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital


What happens when biotech disrupts cannabis issues? - Franck Pradier, Managing Director, Alkion BioInnovations


Engineering Cannabis of the Future: What to Expect - Ying Shao, CEO & Co‑Founder, Plantik Biosciences

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

What are the plans to distribute locally-cultivated medical cannabis flowers for the German market? - Johann Benedikt Sons, CEO & Co‑Founder, Cansativa


From seeds to patients, how does the European medical cannabis market look like? - Bernhard Babel, Co‑CEO, Eurox Group and David Reckeweg-Lecompte, Co‑CEO, Eurox Group


How is the quality of natural extracts a challenge for the medical cannabis industry? - Nora Rossini, Scientific Affairs Manager, Linnea


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital


What happens when biotech disrupts cannabis issues? - Franck Pradier, Managing Director, Alkion BioInnovations


Engineering Cannabis of the Future: What to Expect - Ying Shao, CEO & Co‑Founder, Plantik Biosciences

13:25

Lunch with Networking

14:55

Decreasing Complexity in the European Medical Cannabis Market

  • Fast Track Access to EU medical cannabis market
  • Democratization of market
  • Advantages for producers and patients

Patrick Hoffmann

Co‑Founder
Cantourage
Germany

This session is in English

Decreasing Complexity in the European Medical Cannabis Market

  • Fast Track Access to EU medical cannabis market
  • Democratization of market
  • Advantages for producers and patients

Patrick Hoffmann

Co‑Founder
Cantourage
Germany

This session is in English

Growing a Cannabis Brand Online: How Can Data Be Used to Scale?

  • Using data to decide which product(s) to launch and the appropriate distribution channels
  • How data can help companies to target audience and position their brands
  • Optimizing a cannabis brand's growth using SEO and performance marketing

Alexej Pikovsky

CEO & Co‑Founder
Alphagreen Group
United Kingdom

This session is in English

Growing a Cannabis Brand Online: How Can Data Be Used to Scale?

  • Using data to decide which product(s) to launch and the appropriate distribution channels
  • How data can help companies to target audience and position their brands
  • Optimizing a cannabis brand's growth using SEO and performance marketing

Alexej Pikovsky

CEO & Co‑Founder
Alphagreen Group
United Kingdom

This session is in English

15:25

A Bright Future for Legalization: What Can be Learnt from Luxembourg and Belgium?

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

A Bright Future for Legalization: What Can be Learnt from Luxembourg and Belgium?

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

15:55

Smokable Hemp in Europe: Legal Framework and Future Perspective

  • Presentation of hemp tobacco subsidiaries in Switzerland and Europe
  • A comparative analysis of the legal framework in Europe
  • The state of the smokable hemp market in France
  • Opportunities for French/European hemp producers

Karolina Willoqueaux

Vice President
Totum Group
Switzerland

This session is in English

Smokable Hemp in Europe: Legal Framework and Future Perspective

  • Presentation of hemp tobacco subsidiaries in Switzerland and Europe
  • A comparative analysis of the legal framework in Europe
  • The state of the smokable hemp market in France
  • Opportunities for French/European hemp producers

Karolina Willoqueaux

Vice President
Totum Group
Switzerland

This session is in English

Hemp Application in Eco-Friendly Building

  • The new developed materials comparison to standard building materials
  • Living well-being with hemp building materials

Mariaelena Alessandrini

CEO & Co‑Founder
EDILCANAPA business division of METALINEA
Italy

This session is in English

Hemp Application in Eco-Friendly Building

  • The new developed materials comparison to standard building materials
  • Living well-being with hemp building materials

Mariaelena Alessandrini

CEO & Co‑Founder
EDILCANAPA business division of METALINEA
Italy

This session is in English

16:25

The Possibility of Waste-Free Use of Hemp Under the Concept of Sustainable Development

  • Hemp as a waste-free resource across many sectors
  • Is industrial use of hemp the answer for adverse environmental changes?
  • Cannabis and Corporate Social Responsibility

Marcin Krzyżkowiak

Founder
CannArch
Poland

This session is in English

The Possibility of Waste-Free Use of Hemp Under the Concept of Sustainable Development

  • Hemp as a waste-free resource across many sectors
  • Is industrial use of hemp the answer for adverse environmental changes?
  • Cannabis and Corporate Social Responsibility

Marcin Krzyżkowiak

Founder
CannArch
Poland

This session is in English

New Breeding Techniques for Improving Cannabis Crops

  • The new breeding techniques allow breeders to obtain new varieties in one generation
  • In-vitro culture provides healthy and stronger plants with a greater amount of desired cannabinoids

Veronica Codesido

CCO & Co‑Founder
MIFCO Biosciences
Spain

This session is in English

New Breeding Techniques for Improving Cannabis Crops

  • The new breeding techniques allow breeders to obtain new varieties in one generation
  • In-vitro culture provides healthy and stronger plants with a greater amount of desired cannabinoids

Veronica Codesido

CCO & Co‑Founder
MIFCO Biosciences
Spain

This session is in English

16:55

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can complexities in the EU medical cannabis market be reduced? - Patrick Hoffmann, Co‑Founder, Cantourage


What can be learnt from the Luxembourg and Belgium markets? - Miles Voigt, Chief Sales Officer, AE Grünkraft


How does the future of smokable hemp in Europe look like? - Karolina Willoqueaux, Vice President, Totum Group


How can hemp be used sustainably and without waste? - Marcin Krzyżkowiak, Founder, CannArch

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

How can complexities in the EU medical cannabis market be reduced? - Patrick Hoffmann, Co‑Founder, Cantourage


What can be learnt from the Luxembourg and Belgium markets? - Miles Voigt, Chief Sales Officer, AE Grünkraft


How does the future of smokable hemp in Europe look like? - Karolina Willoqueaux, Vice President, Totum Group


How can hemp be used sustainably and without waste? - Marcin Krzyżkowiak, Founder, CannArch

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cosmetics and Beauty Market: CBD is the New Black! - Joanna Weaver-Pélissier, CEO, Be Cann


How can hemp be applied towards eco-friendly buildings? - Mariaelena Alessandrini, CEO & Co‑Founder, EDILCANAPA business division of METALINEA

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cosmetics and Beauty Market: CBD is the New Black! - Joanna Weaver-Pélissier, CEO, Be Cann


How can hemp be applied towards eco-friendly buildings? - Mariaelena Alessandrini, CEO & Co‑Founder, EDILCANAPA business division of METALINEA

17:40

End of the Conference with Summary

Book Your Tickets

World Class Unlimited Online Pass

Access the presentations from this conference online as well as hundreds of other case study videos from global business leaders. The videos are full-length and include the PDFs of the presentation. More videos are added each month with new World Class Business Leaders business transformation conferences bringing best practices to you from around the world. Don't lose this opportunity to stay on top of what business leaders currently do and plan for the future to gain a competitive edge. 12 months of World Class Unlimited are included in any of the Conference Passes.

Book World Class Unlimited Online Pass

Travel & Accommodation

Dorint Hotel Frankfurt/Oberursel
Königsteiner Straße 29
61440 Oberursel

For deliveries*, please add to the address the following phrase:
"22nd + 23rd of June 2021 & WCBLeaders"

*Please note that all deliveries should arrive at the hotel a maximum of 2 days before the event.

PREFERENTIAL RATES:
Secure your accommodation at the Dorint Hotel Frankfurt/Oberursel (https://hotel-frankfurt-oberursel.dorint.com/en) for the exclusive price of €129/night (incl. breakfast) or €120/night (without breakfast) for a single room, or €149/night (incl. breakfast) or €140/night (without breakfast) for a double room.

Please contact the hotel reservation at +49 6171 2769-922 or reservierung.oberursel@dorint.com and use the code "CBE21“ to get the special price.

Use the offer of the cooperation partner Deutsche Bahn for your travel: Click here

PARKING FEES:
Parking is available at the Dorint Hotel Frankfurt/Oberursel. 70 lots are available at the park garage at €2 per hour, €17 per day, while there are 120 lots available at the external parking space, at €1 per hour, €7 per day.

MORE INFORMATION:
To visit the hotel's website and to obtain more information, please click here or contact the hotel at +49 6171 2769-922 or reservierung.oberursel@dorint.com.

Supported by Partners such as

Think Tank

As a registered attendee, visit the event’s online think tank where you can see your fellow attendees’ profiles and priorities to get in touch, arrange meetings and collaborate with your best networking opportunities. Also, your conference documentation awaits you in this World Class Business Leaders think tank.

Visit the Think Tank

Contributors

Become a Speaker or Sponsor

We are looking for the best practices that shape tomorrow's world. If you would like to contribute to this event as speaker, please fill out the speaker application form here.

If you have already been in contact with the event organization team and are confirming the details of your presentation, please access the speaker questionnaire here.

Get in front of top decision makers of your field! In total, we expect more than € 100M in budgets attending. To get more information and make your business grow, inquire here.

Downloads

Download additional materials about the conference. You will find flyers, logos, banners, signature templates as well as press releases.

Download Conference Materials

Matchmaking-powered Event Experience and Unique Networking Service

100% embedded into the World Class Business platform.

See who you definitely need to network with.

Manage your networking meetings.

Best practices and experts remain only a click away after the event.

...